The Basilar Artery International Cooperation Study (BASICS): Study protocol for a randomised controlled trial

Trials

Volumn 14, Issue 1, 2013, Pages

  van der Hoeven, Erik J R J ^a   Schonewille, Wouter J ^a   Vos, Jan Albert ^a   Algra, Ale ^b,c   Audebert, Heinrich J ^d   Berge, Eivind ^e   Ciccone, Alfonso ^f   Mazighi, Mikael ^g   Michel, Patrik ^h   Muir, Keith W ⁱ   Obach, Víctor ^j   Puetz, Volker ^k   Wijman, Cristanne A C ^l   Zini, Andrea ^m   Kappelle, Jaap L ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f CARLO POMA HOSPITAL   (Italy)

^g BICHAT HOSPITAL   (France)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j HOSPITAL CLÍNIC   (Spain)

^k UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^l STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

more..

Author keywords

Basilar artery occlusion; Basilar artery thrombosis; Intra arterial treatment; Intravenous thrombolysis; Stroke

Indexed keywords

ALTEPLASE;

ARTICLE; BASILAR ARTERY OBSTRUCTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE REGISTRY; FIBRINOLYTIC THERAPY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL CARE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASILAR ARTERY; CEREBRAL ANGIOGRAPHY; CLINICAL PROTOCOLS; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; REGISTRIES; RESEARCH DESIGN; THROMBOLYTIC THERAPY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY; YOUNG ADULT;

EID: 84879815124     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-200     Document Type: Article

References (30)

1. Leys D. Atherothrombosis: a major health burden. Cerebrovasc Dis 2001, 2:1-4.
2. Schonewille WJ, Wijman CA, Michel P, Rueckert CM, Weimar C, Mattle HP, Engelter ST, Tanne D, Muir KW, Molina CA, Thijs V, Audebert H, Pfefferkorn T, Szabo K, Lindsberg PJ, de Freitas G, Kappelle LJ, Algra A. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009, 8:724-730. 10.1016/S1474-4422(09)70173-5, 19577962.
3. Group. TNIoNDaSr-PASS Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587. Group. TNIoNDaSr-PASS.
4. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003-2011.
5. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245-1251.
6. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley ECJ, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768-774.
7. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317-1329. 10.1056/NEJMoa0804656, 18815396.
8. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007, 38:2633-2639. 10.1161/STROKEAHA.107.488551, 17702958.
9. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006, 67:334-336. 10.1212/01.wnl.0000224759.44743.7d, 16864834.
10. Weimar C, Goertler M, Harms L, Diener HC. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol 2006, 63:1287-1291. 10.1001/archneur.63.9.1287, 16966507.
11. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005, 20:12-17. 10.1159/000086121, 15925877.
12. Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturzenegger M, Schuknecht B, Mattle HP. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004, 75:857-862. 10.1136/jnnp.2003.020479, 1739049, 15146000.
13. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006, 37:922-928. 10.1161/01.STR.0000202582.29510.6b, 16439705.
14. Mattle HP, Arnold M, Lindsberg PJ, Schonewille WJ, Schroth G. Basilar artery occlusion. Lancet Neurol 2011, 10:1002-1014. 10.1016/S1474-4422(11)70229-0, 22014435.
15. Pocock SJ. Clinical Trials: A Practical Approach 1983, London: Wiley.
16. Whitehead J. The Design and Analysis of Sequential Clinical Trials 1997, London: Wiley, 2.
17. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998, 29:4-11.
18. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008, 3:130-137. 10.1111/j.1747-4949.2008.00151.x, 3057361, 18706007.
19. Ferbert A, Bruckmann H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke 1990, 21:1135-1142. 10.1161/01.STR.21.8.1135, 2389292.
20. Baird TA, Muir KW, Bone I. Basilar artery occlusion. Neurocrit Care 2004, 1:319-329. 10.1385/NCC:1:3:319, 16174929.
21. Muller R, Pfefferkorn T, Vatankhah B, Mayer TE, Schenkel J, Dichgans M, Sander D, Audebert HJ. Admission facility is associated with outcome of basilar artery occlusion. Stroke 2007, 38:1380-1383. 10.1161/01.STR.0000260089.17105.27, 17322095.
22. Vergouwen MD, Algra A, Pfefferkorn T, Weimar C, Rueckert CM, Thijs V, Kappelle LJ, Schonewille WJ. Time is brain(stem) in basilar artery occlusion. Stroke 2012, 43:3003-3006. 10.1161/STROKEAHA.112.666867, 22989501.
23. IMS Study Investigators Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35:904-911. IMS Study Investigators.
24. IMS II Trial Investigators The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38:2127-2135. IMS II Trial Investigators.
25. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598-2605. 10.1161/01.STR.30.12.2598, 10582984.
26. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA. Interventional Management of Stroke (IMS) III Investigators: Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013, 368:893-903. 10.1056/NEJMoa1214300, 23390923.
27. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012, 380:1231-1240. 10.1016/S0140-6736(12)61299-9, 22932714.
28. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012, 380:1241-1249. 10.1016/S0140-6736(12)61384-1, 22932715.
29. Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS, Cacayorin ED, Grotta JC, Noser EA. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?. Stroke 2007, 38:80-84. 10.1161/STROKEAHA.107.486126, 17122433.
30. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009, 40:3777-3783. 10.1161/STROKEAHA.109.561431, 19875740.